JMP Securities reaffirmed their market perform rating on shares of Simulations Plus (NASDAQ:SLP - Free Report) in a research report report published on Wednesday morning,Benzinga reports.
SLP has been the topic of a number of other research reports. William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Tuesday, June 3rd. KeyCorp boosted their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a report on Wednesday, April 16th. Craig Hallum cut their price target on shares of Simulations Plus from $45.00 to $36.00 and set a "buy" rating on the stock in a report on Friday, June 13th. Finally, Wall Street Zen upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a research note on Monday, April 28th. Two research analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $41.25.
Get Our Latest Analysis on Simulations Plus
Simulations Plus Trading Down 4.1%
Shares of NASDAQ SLP traded down $0.75 during midday trading on Wednesday, reaching $17.33. The company's stock had a trading volume of 538,888 shares, compared to its average volume of 245,355. Simulations Plus has a one year low of $17.04 and a one year high of $49.71. The company has a 50 day moving average price of $29.78 and a 200 day moving average price of $29.66. The company has a market cap of $348.51 million, a price-to-earnings ratio of 49.51 and a beta of 0.97.
Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. Simulations Plus had a net margin of 9.18% and a return on equity of 7.86%. The business had revenue of $22.43 million for the quarter, compared to analyst estimates of $21.93 million. During the same quarter in the previous year, the business earned $0.20 earnings per share. The firm's revenue was up 22.5% compared to the same quarter last year. Research analysts anticipate that Simulations Plus will post 1.09 earnings per share for the current fiscal year.
Insider Buying and Selling at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total value of $670,200.00. Following the completion of the sale, the director now directly owns 3,344,157 shares of the company's stock, valued at $112,062,701.07. The trade was a 0.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 19.40% of the company's stock.
Institutional Trading of Simulations Plus
Large investors have recently added to or reduced their stakes in the business. Proficio Capital Partners LLC bought a new stake in Simulations Plus in the fourth quarter worth approximately $719,000. North Star Investment Management Corp. bought a new stake in Simulations Plus in the first quarter worth approximately $1,300,000. D. E. Shaw & Co. Inc. boosted its holdings in shares of Simulations Plus by 100.0% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 53,332 shares of the technology company's stock worth $1,487,000 after buying an additional 26,661 shares during the period. Sei Investments Co. bought a new stake in shares of Simulations Plus during the 4th quarter worth $330,000. Finally, Northern Trust Corp boosted its holdings in shares of Simulations Plus by 10.0% during the 4th quarter. Northern Trust Corp now owns 236,373 shares of the technology company's stock worth $6,592,000 after buying an additional 21,453 shares during the period. 78.08% of the stock is owned by institutional investors.
Simulations Plus Company Profile
(
Get Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Stories

Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.